Please assess the completion status of the following clinical trial:

Trial Title: Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age over 18 years.~* First metastatic breast cancer relapse after treatment for early stage disease~* A minimum of 10 evaluable lesions in the liver on routine x-ray CT imaging~* Patient prescribed cytotoxic, endocrine or biological therapies~* Patient physically and psychologically fit enough to consider sequential WB-- - DWI imaging alongside their standard disease monitoring~* Written informed consent~Exclusion Criteria:~* Diagnosis of other cancer within the last 5 years, other than resected non-melanoma skin cancer or cervical intraepithelial neoplasia~* Diagnosis of brain metastases.~* Contraindication to magnetic resonance MR imaging

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).